Probity Advisors, Inc. Eli Lilly & CO Transaction History

Probity Advisors, Inc.

$515 Million
Q3 2024

A detailed history of Probity Advisors, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Probity Advisors, Inc. holds 3,658 shares of LLY stock, worth $2.85 Million. This represents 0.63% of its overall portfolio holdings.

Number of Shares

3,658

Previous 3,993 8.39%

Holding current value

$2.85 Million

Previous $3.62 Million 10.37%

% of portfolio

0.63%

Previous 0.76%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 16, 2024	SELL	$772.14 - $960.02 $258,666 - $321,606	-335 Reduced 8.39%	3,658 $3.24 Million
Q2 2024 Aug 14, 2024	SELL	$724.87 - $909.04 $292,122 - $366,343	-403 Reduced 9.17%	3,993 $3.62 Million
Q1 2024 May 02, 2024	SELL	$592.2 - $792.28 $222,075 - $297,105	-375 Reduced 7.86%	4,396 $3.42 Million
Q4 2023 Feb 12, 2024	SELL	$525.19 - $619.13 $173,312 - $204,312	-330 Reduced 6.47%	4,771 $2.78 Million
Q3 2023 Nov 14, 2023	SELL	$434.7 - $599.3 $64,770 - $89,295	-149 Reduced 2.84%	5,101 $2.74 Million
Q2 2023 Aug 10, 2023	SELL	$350.74 - $468.98 $147,661 - $197,440	-421 Reduced 7.42%	5,250 $2.46 Million
Q4 2022 Feb 14, 2023	SELL	$321.55 - $374.67 $229,265 - $267,139	-713 Reduced 11.17%	5,671 $2.07 Million
Q3 2022 Nov 14, 2022	SELL	$296.48 - $337.87 $187,078 - $213,195	-631 Reduced 9.0%	6,384 $2.06 Million
Q2 2022 Aug 12, 2022	SELL	$278.73 - $327.27 $59,090 - $69,381	-212 Reduced 2.93%	7,015 $2.27 Million
Q1 2022 May 10, 2022	SELL	$234.69 - $291.66 $179,303 - $222,828	-764 Reduced 9.56%	7,227 $2.07 Million
Q4 2021 Feb 10, 2022	SELL	$224.85 - $279.04 $119,845 - $148,728	-533 Reduced 6.25%	7,991 $2.21 Million
Q3 2021 Oct 08, 2021	SELL	$221.6 - $272.71 $109,248 - $134,446	-493 Reduced 5.47%	8,524 $1.97 Million
Q2 2021 Aug 06, 2021	SELL	$180.55 - $233.54 $149,314 - $193,137	-827 Reduced 8.4%	9,017 $2.07 Million
Q1 2021 Apr 28, 2021	SELL	$164.32 - $212.72 $229,719 - $297,382	-1,398 Reduced 12.44%	9,844 $1.84 Million
Q3 2020 Nov 09, 2020	SELL	$146.22 - $169.13 $91,972 - $106,382	-629 Reduced 5.3%	11,242 $1.66 Million
Q2 2020 Aug 03, 2020	SELL	$136.42 - $164.18 $51,976 - $62,552	-381 Reduced 3.11%	11,871 $1.95 Million
Q1 2020 May 15, 2020	SELL	$119.05 - $147.35 $50,953 - $63,065	-428 Reduced 3.38%	12,252 $1.7 Million
Q4 2019 Feb 13, 2020	SELL	$106.92 - $132.43 $12,723 - $15,759	-119 Reduced 0.93%	12,680 $1.67 Million
Q3 2019 Nov 14, 2019	SELL	$106.79 - $116.16 $9,611 - $10,454	-90 Reduced 0.7%	12,799 $1.43 Million
Q2 2019 Aug 08, 2019	SELL	$110.79 - $129.32 $52,182 - $60,909	-471 Reduced 3.53%	12,889 $1.43 Million
Q1 2019 Apr 29, 2019	SELL	$111.31 - $131.02 $17,253 - $20,308	-155 Reduced 1.15%	13,360 $1.73 Million
Q4 2018 Feb 12, 2019	SELL	$105.9 - $118.64 $47,125 - $52,794	-445 Reduced 3.19%	13,515 $1.56 Million
Q3 2018 Nov 14, 2018	SELL	$85.86 - $107.31 $21,722 - $27,149	-253 Reduced 1.78%	13,960 $1.5 Million
Q2 2018 Aug 13, 2018	BUY	$75.7 - $86.88 $13,853 - $15,899	183 Added 1.3%	14,213 $1.21 Million
Q1 2018 Apr 16, 2018	BUY	$74.21 - $87.6 $34,952 - $41,259	471 Added 3.47%	14,030 $1.09 Million
Q4 2017 Feb 09, 2018	BUY	$81.94 - $87.89 $38,921 - $41,747	475 Added 3.63%	13,559 $1.15 Million
Q3 2017 Oct 27, 2017	BUY	$77.07 - $85.54 $1.01 Million - $1.12 Million	13,084	13,084 $1.12 Million

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $740B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Probity Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Probity Advisors, Inc. with notifications on news.

Account

Probity Advisors, Inc. Eli Lilly & CO Transaction History